CELLINK partners with CTI BIOTECH for 3D bioprinted cancer research
3D Printing Industry
JANUARY 10, 2018
Swedish 3D bioprinter provider CELLINK has released details of a partnership with French regenerative medicine research and development company CTI BIOTECH. A fully licensed human tissue biobank, CTI BIOTECH is using CELLINK 3D bioprinters to create tumorous tissue models in-lab, and investigate new therapies for patients with cancer. Professor Colin McGuckin, Founder of CTI BIOTECH, said, […].